Case report: adult onset diabetes with partial pancreatic agenesis and congenital heart disease due to a de novo GATA6 mutation.
Adult-onset
Diabetes
GATA6
Pancreatic agenesis
Treatment
Journal
BMC medical genetics
ISSN: 1471-2350
Titre abrégé: BMC Med Genet
Pays: England
ID NLM: 100968552
Informations de publication
Date de publication:
03 04 2020
03 04 2020
Historique:
received:
04
07
2019
accepted:
25
03
2020
entrez:
5
4
2020
pubmed:
5
4
2020
medline:
6
5
2020
Statut:
epublish
Résumé
Mutations in GATA6 are the most frequent cause of pancreatic agenesis. Most cases present with neonatal diabetes mellitus. The case was a female born after an uncomplicated pregnancy and delivery in a non-consanguineous family (3.59 kg, 70th percentile). Severe cardiac malformations were diagnosed at two and a half months old. No hyperglycaemic episodes were recorded in the neonatal period. Diabetes was diagnosed at 21 years due to the detection of incidental glycosuria. She had a low but detectable C-peptide level at diagnosis. Anti-GAD and Islet-cell antibodies were negative and she failed oral hypoglycaemic therapy and was started on insulin. Abdominal MRI revealed the absence of most of the neck, body, and tail of pancreas with normal pancreas elastase levels. Criteria for type 1 or type 2 diabetes were not fulfilled, therefore a next generation sequencing (NGS) panel was performed. A novel heterozygous pathogenic GATA6 mutation (p.Tyr235Ter) was identified. The GATA6 variant was not detected in her parents, implying that the mutation had arisen de novo in the proband. Rarely GATA6 mutations can cause adult onset diabetes. This report highlights the importance of screening the GATA6 gene in patients with adult-onset diabetes, congenital cardiac defects and pancreatic agenesis with no first-degree family history of diabetes. It also emphasizes the importance of genetic counselling in these patients as future offspring will be at risk of inheriting the variant and developing GATA6 anomalies.
Sections du résumé
BACKGROUND
Mutations in GATA6 are the most frequent cause of pancreatic agenesis. Most cases present with neonatal diabetes mellitus.
CASE PRESENTATION
The case was a female born after an uncomplicated pregnancy and delivery in a non-consanguineous family (3.59 kg, 70th percentile). Severe cardiac malformations were diagnosed at two and a half months old. No hyperglycaemic episodes were recorded in the neonatal period. Diabetes was diagnosed at 21 years due to the detection of incidental glycosuria. She had a low but detectable C-peptide level at diagnosis. Anti-GAD and Islet-cell antibodies were negative and she failed oral hypoglycaemic therapy and was started on insulin. Abdominal MRI revealed the absence of most of the neck, body, and tail of pancreas with normal pancreas elastase levels. Criteria for type 1 or type 2 diabetes were not fulfilled, therefore a next generation sequencing (NGS) panel was performed. A novel heterozygous pathogenic GATA6 mutation (p.Tyr235Ter) was identified. The GATA6 variant was not detected in her parents, implying that the mutation had arisen de novo in the proband.
CONCLUSION
Rarely GATA6 mutations can cause adult onset diabetes. This report highlights the importance of screening the GATA6 gene in patients with adult-onset diabetes, congenital cardiac defects and pancreatic agenesis with no first-degree family history of diabetes. It also emphasizes the importance of genetic counselling in these patients as future offspring will be at risk of inheriting the variant and developing GATA6 anomalies.
Identifiants
pubmed: 32245430
doi: 10.1186/s12881-020-01012-2
pii: 10.1186/s12881-020-01012-2
pmc: PMC7118888
doi:
Substances chimiques
GATA6 Transcription Factor
0
GATA6 protein, human
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
70Références
Diagn Pathol. 2017 Jan 3;12(1):1
pubmed: 28049534
Diabetes. 2018 Mar;67(3):448-460
pubmed: 29263149
Mol Endocrinol. 2008 Apr;22(4):781-98
pubmed: 18174356
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Lancet. 2015 Sep 5;386(9997):957-63
pubmed: 26231457
J Biol Chem. 2000 Dec 15;275(50):38949-52
pubmed: 11042222
Diabetologia. 2013 Sep;56(9):1958-63
pubmed: 23771172
Am J Med Genet A. 2019 Sep;179(9):1836-1845
pubmed: 31301121
Pediatr Res. 2010 Oct;68(4):281-5
pubmed: 20581743
Diabetologia. 2012 Oct;55(10):2845-2847
pubmed: 22806356
Nat Rev Nephrol. 2015 Feb;11(2):102-12
pubmed: 25536396
PLoS One. 2015 Feb 23;10(2):e0118449
pubmed: 25706805
J Clin Endocrinol Metab. 2018 Jan 1;103(1):35-45
pubmed: 28938416
Diabetes. 2013 Mar;62(3):993-7
pubmed: 23223019
J Med Genet. 2012 Oct;49(10):642-3
pubmed: 22962692
Nat Genet. 2011 Dec 11;44(1):20-22
pubmed: 22158542
Clin Perinatol. 2018 Mar;45(1):41-59
pubmed: 29406006